Ask AI
ProCE Banner Activity

Express Points
AL Amyloidosis: Advances in Early Diagnosis, Treatment Options, and Individualized Care

Slideset Download
Downloadable summary slideset on the key takeaways from a live symposium on diagnosing and typing AL amyloidosis, and managing newly diagnosed and relapsed/refractory disease.

Released: December 16, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Alexion Pharmaceuticals

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Program Director Disclosure

Program Director

Angela Dispenzieri, MD

Consultant
Division of Hematology
Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine 
Mayo Clinic
Rochester, Minnesota 

Faculty Disclosure

Primary Author

Anita D'Souza, MD

Professor of Medicine
Associate Chief of Research, Division of Hematology and Oncology
Chair, Plasma Cell Disorders, Froedtert & MCW Cancer Center
Medical College of Wisconsin
Milwaukee, Wisconsin

Anita D’Souza, MD: consultant/advisor/speaker: Bristol-Myers Squibb, Janssen, Prothena; researcher: AbbVie, Caelum, Janssen, Prothena, Regeneron, Sanofi, Takeda, TeneoBio.

Jeffrey Zonder, MD

Professor of Oncology  
Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine
Detroit, Michigan

Jeffrey Zonder, MD: consultant/advisor/speaker: Caelum/AstraZeneca, Intellia, Janssen, Prothena, Regeneron, Takeda; researcher: Bristol-Myers Squib